|Bid||148.00 x 100|
|Ask||148.11 x 300|
|Day's Range||146.50 - 148.18|
|52 Week Range||133.82 - 178.86|
|PE Ratio (TTM)||6.51|
|Earnings Date||May 16, 2018 - May 21, 2018|
|Forward Dividend & Yield||1.36 (0.92%)|
|1y Target Est||180.69|
Shares of Cardinal Health, McKesson, AmerisourceBergen, Walgreens Boots Alliance and CVS Health all rose on the news.
A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.
Examining McKesson Corporation’s (NYSE:MCK) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations, which isRead More...
COLUMBUS, Ohio (AP) — A federal judge with an audacious plan to settle hundreds of lawsuits filed by local governments against the drug industry over the destruction wrought by prescription opioid painkillers has altered his course.
Adynxx's first goal is to have its experimental drug block post-surgical pain, but in doing that it appears to have an effect on how many addictive opioids patients will pop.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
Netsmart will acquire the home health and hospice businesses from one of the world's largest health care companies.
The co-working company, valued at $20 billion, shows no signs of slowing after a blockbuster year in 2017.
Opioids were responsible for 115 deaths of Americans per day in 2016. Now the San Francisco-based company responsible for distributing many of those painkillers is proposing ways to fight the opioid crisis.
Stocks, such as McKesson, trading at a market price below their true values are considered to be undervalued. There’s a few ways you can measure the value of a companyRead More...
Let's see if McKesson Corporation (MCK) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting MCK. Over the last one-month, outflows of investor capital in ETFs holding MCK totaled $2.54 billion.
Depomed (DEPO) has adopted a three-pronged business strategy with three key elements: maintain, build, and grow. Depomed aims to maintain its Nucynta franchise of pain products through the commercialization agreement it entered into with Collegium Pharmaceutical in December 2017. Under this agreement, Depomed granted commercialization rights for the Nucynta franchise of pain products to Collegium Pharmaceutical in the US.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and ...
WASHINGTON (AP) — The Justice Department said Tuesday it will support local officials in hundreds of lawsuits against manufacturers and distributors of powerful opioid painkillers that are fueling the nation's drug abuse crisis.
AmerisourceBergen must enact sweeping reforms that address its role in the opioid crisis, says Teamsters' Treasurer Ken Hall.
Ohio on Monday accused four major pharmaceutical distributors of ignoring their responsibilities to ensure that opioids were not being diverted for improper uses, contributing to a drug abuse epidemic ...
McKesson Corporation today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to $1,100,000,000 combined aggregate purchase price of its outstanding 6.000% Notes due 2041 , 7.650% Debentures due 2027 , 4.883% Notes due 2044 , 4.750% Notes due 2021 and 7.500% Notes due 2019 .
McKesson Corporation today announced the early tender results as of the Early Tender Time in connection with its previously announced cash tender offer to purchase up to $1,100,000,000 combined aggregate purchase price of its outstanding 6.000% Notes due 2041 , 7.650% Debentures due 2027 , 4.883% Notes due 2044 , 4.750% Notes due 2021 and 7.500% Notes due 2019 .
LONDON, UK / ACCESSWIRE / February 21, 2018 / Active-Investors.com has just released a free earnings report on McKesson Corp. (NYSE: MCK ). If you want access to this report all you need to do is sign ...